Zusammenfassung
Drug Repurposing (DR) beschreibt die Suche nach neuen therapeutischen Einsatzmöglichkeiten für bereits zugelassene Arzneimittel. Doch wie können entsprechende Hypothesen mittels bereits bestehenden Daten formuliert werden?
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Jarada TN, Rokne JG, Alhajj R. A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions. Journal of cheminformatics. 2020;12(1):1–23.
Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nature reviews Drug discovery. 2019;18(1):41–58.
Ledford H. Dozens of coronavirus drugs are in development – what happens next? Nature. 2020;581(7808):247–9.
DiMasi JA. Risks in new drug development: approval success rates for investigational drugs. Clinical Pharmacology & Therapeutics. 2001;69(5):297–307.
Serafin MB, Bottega A, Foletto VS, da Rosa TF, Hörner A, Hörner R. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. International Journal of Antimicrobial Agents. 2020;55(6):105969.
Harris M, Bhatti Y, Buckley J, Sharma D. Fast and frugal innovations in response to the COVID-19 pandemic. Nature Medicine. 2020;26(6):814–7.
Zhu F, Patumcharoenpol P, Zhang C, Yang Y, Chan J, Meechai A, et al. Biomedical text mining and its applications in cancer research. Journal of biomedical informatics. 2013;46(2):200–11.
Han P, Yang P, Zhao P, Shang S, Liu Y, Zhou J, et al., editors. GCN-MF: disease-gene association identification by graph convolutional networks and matrix factorization. Proceedings of the 25th ACM SIGKDD international conference on knowledge discovery & data mining; 2019
Nugent T, Plachouras V, Leidner JL. Computational drug repositioning based on side-effects mined from social media. PeerJ Computer Science. 2016;2:e46.
Udrescu L, Sbârcea L, Topîrceanu A, Iovanovici A, Kurunczi L, Bogdan P, et al. Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing. Scientific reports. 2016;6(1):1–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Der/die Autor(en), exklusiv lizenziert an Springer Fachmedien Wiesbaden GmbH, ein Teil von Springer Nature
About this chapter
Cite this chapter
Koß, J. (2023). Drug Repurposing mittels künstlicher Intelligenz. In: Bohnet-Joschko, S., Pilgrim, K. (eds) Handbuch Digitale Gesundheitswirtschaft . Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-41781-9_19
Download citation
DOI: https://doi.org/10.1007/978-3-658-41781-9_19
Published:
Publisher Name: Springer Gabler, Wiesbaden
Print ISBN: 978-3-658-41780-2
Online ISBN: 978-3-658-41781-9
eBook Packages: Business and Economics (German Language)